Skip to main content
. 2022 Oct 12;13:1022403. doi: 10.3389/fmicb.2022.1022403

Figure 7.

Figure 7

Schematic diagram showing the possible mechanisms of Huang-Qi-Ling-Hua-San ameliorating type 2 diabetes via Christensenella. HQLHS treatment inhibited harmful bacteria and enriched beneficial bacteria, especially Christensenella. Christensenella promoted the production of GLP-1; Reduced the expression of GLUT2 and SGLT1, thereby inhibiting the transport of glucose in the small intestine; Increased the expression of ZO-1 and Claudin-1, thus decreasing the entry of LPS into the periphery, and reduced inflammation through LPS/TLR4/NF-κB; Improved the activity of antioxidant enzymes; Decreased the expression of G-6-Pase and PEPCK, which inhibited gluconeogenesis; Increased the synthesis of liver glycogen; Regulated liver metabolites such as BCAAs, tryptophan, kynurenate, and taurine.